PREDICTIVE ONCOLOGY INC (POAI)
US74039M3097 - Common Stock
POAI Stock Earnings: Predictive Oncology Reported Results for Q4 2023
Predictive Oncology just reported results for the fourth quarter of 2023.
POAI Stock Earnings: Predictive Oncology Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Predictive Oncology (NASDAQ:POAI) just reported results for the fourth quarter ...
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
Company to host investor call and webcast on Monday, April 1st, at 8:30am EDT
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
Company to host investor call and webcast on Monday, April 1st, at 8:30am EDT...
Predictive Oncology to Participate in Upcoming Investor Conferences
3 Penny Stocks That Will Be the Surefire AI Winners of Tomorrow
AI penny stocks carry substantial risk, but also offer the potential for massive upside; here are three stocks for your 2024 watchlist.
Predictive Oncology to Participate in Upcoming San Francisco Conferences
Predictive Oncology to Participate in Upcoming San Francisco Conferences
PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today...
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Company to host investor call and webcast today, November 14th, at 8:30am EDT
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Company to host investor call and webcast today, November 14th, at 8:30am EDT...
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced...
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
Management to host conference call and webcast at 8:30am EDT
3 AI Stocks Worth Buying Now for Multibagger Returns
With no signs of artificial intelligence cooling, we could be looking at a potential $1.8 trillion opportunity for AI stocks.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday!
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
Company to host investor call and webcast today, August 10th, at 5:30pm EDT
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
Company to host investor call and webcast today, August 10th, at 5:30pm EDT...
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
Management to host conference call and webcast at 5:30pm EDT
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
Management to host conference call and webcast at 5:30pm EDT...
3 AI Stocks to Buy Under $10 in August 2023
The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10.
7 AI Penny Stocks that Could Hit $5 Soon
Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence.
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
Surrounded by world renowned universities and medical centers,Predictive Oncology is part of the next generation of Pittsburgh’s innovation ecosystem ...
Big Tech on the Prowl: 3 Potential AI Stock Acquisition Targets
With the artificial intelligence boom gaining momentum, we’re likely to see far more interest in AI stocks.
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial...
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
/PRNewswire/ -- Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other...
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial...
3 Penny Stocks That Have Game-Changing Technologies
As the AI bubble inflates, now is a time for risk-tolerant investors to think about the best tech-based penny stocks
3 Pharma Stocks That Will Boom Thanks to AI
Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms.
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
Pamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity with AI to solve the missing link in drug discovery
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
Pamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity with AI to solve the missing...